BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21356166)

  • 1. Chronic lymphocytic leukemia: prognostic factors and impact on treatment.
    Parker TL; Strout MP
    Discov Med; 2011 Feb; 11(57):115-23. PubMed ID: 21356166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.
    Zent CS; Kay NE
    Leuk Lymphoma; 2011 Aug; 52(8):1425-34. PubMed ID: 21649549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
    Van Roosbroeck K; Calin GA
    Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostication in chronic lymphocytic leukemia.
    Moia R; Gaidano G
    Semin Hematol; 2024 Apr; 61(2):83-90. PubMed ID: 38523019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing frontline therapy of CLL based on clinical and biological factors.
    Fischer K; Hallek M
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):338-345. PubMed ID: 29222276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CRNDE is downregulated and associated with poor prognostic markers in chronic lymphocytic leukemia.
    Shehata AMF; Gohar SF; Muharram NM; Soliman SS; Shalaby HM; Kamal Eldin SM; El-Bassal FI
    Int J Lab Hematol; 2024 Feb; 46(1):107-112. PubMed ID: 37814899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat CLL up front.
    Gribben JG
    Blood; 2010 Jan; 115(2):187-97. PubMed ID: 19850738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region.
    Alshemmari SH; Siddiqui MA; Pandita R; Osman HY; Cherif H; O'Brien S; Marashi M; Al Farsi K
    Acta Haematol; 2024; 147(3):260-279. PubMed ID: 37751733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine in CLL: current status and future perspectives.
    Rozovski U; Hazan-Halevy I; Keating MJ; Estrov Z
    Cancer Lett; 2014 Sep; 352(1):4-14. PubMed ID: 23879961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic lymphocytic leukemia.
    Ghia P; Hallek M
    Haematologica; 2014 Jun; 99(6):965-72. PubMed ID: 24881042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.
    Syrykh C; Pons-Brun B; Russiñol N; Playa-Albinyana H; Baumann T; Duran-Ferrer M; Kulis M; Carbó-Meix A; Mozas P; Alcoceba M; González M; Navarro-Bailón A; Colado E; Payer ÁR; Aymerich M; Terol MJ; Lu J; Knisbacher BA; Hahn CK; Ruiz-Gaspà S; Enjuanes A; Wu CJ; Getz G; Zenz T; López-Guillermo A; Martín-Subero JI; Colomer D; Delgado J; Campo E; Nadeu F
    Blood Adv; 2023 Dec; 7(23):7384-7391. PubMed ID: 37505099
    [No Abstract]   [Full Text] [Related]  

  • 12. An overview of prognostic markers in patients with CLL.
    Braish J; Cerchione C; Ferrajoli A
    Front Oncol; 2024; 14():1371057. PubMed ID: 38817892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
    Hallek M; Cheson BD; Catovsky D; Caligaris-Cappio F; Dighiero G; Döhner H; Hillmen P; Keating MJ; Montserrat E; Rai KR; Kipps TJ;
    Blood; 2008 Jun; 111(12):5446-56. PubMed ID: 18216293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?
    Alsolami R; Knight SJ; Schuh A
    Per Med; 2013 Jun; 10(4):361-376. PubMed ID: 24611071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia: inception to cure: are we there?
    Lad DP; Malhotra P; Varma S
    Indian J Hematol Blood Transfus; 2013 Mar; 29(1):1-10. PubMed ID: 24426325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.
    Hallek M
    Am J Hematol; 2013 Sep; 88(9):803-16. PubMed ID: 23720127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
    Hallek M
    Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.
    Hallek M
    Am J Hematol; 2017 Sep; 92(9):946-965. PubMed ID: 28782884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia: a clinical review.
    Nabhan C; Rosen ST
    JAMA; 2014 Dec; 312(21):2265-76. PubMed ID: 25461996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis and therapy of chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Sun C; Wiestner A
    Cancer Treat Res; 2015; 165():147-75. PubMed ID: 25655609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.